EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development of A Nano-Emulsion-Based Transdermal Patch for Enhanced Permeation of Anti-Anxiety Drugs

Mrynal Chamoli, Swati Gautam, Manisha Sharma, Sujata Vinod Wankhede, Mohit Kumar, Suresh Babu Kondaveeti, Revan Sudhakar Karodi, Mahesh Kumar Gupta, Ritesh Kumar

Oriental Journal Of Chemistry · 01.03.2026 · 1 (42) · 272

DOI: 10.13005/ojc/420130 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oriental Journal Of Chemistry, online erschienen am 28.02.2026. Verfasst von Mrynal Chamoli und 8 weiteren Autor:innen. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Anxiety disorders, which are one of the most common neuropsychiatric burdens worldwide, are poorly treated with the existing oral pharmacotherapies because of such factors as first-pass metabolism, systemic side effects, slow onset, and lack of patient adherence. Central nervous system drug delivery is also restricted by the blood-brain barrier (BBB). Transdermal delivery is an alternative promising option because the stratum corneum is not bypassed, leading to sustained release, but the stratum corneum is still a major limitation.An optimized Capryol 90tm, Tween 80, and Transcutol P clonazepam-loaded nanoemulsion (CZP-NE) was developed in terms of physicochemical aspects (size, PDI, zeta potential, entrapment efficiency), stability, and morphology (TEM). A transdermal patch was comprised of incorporating the NE into a chitosan-PVP matrix. Franz diffusion cells were used to determine the drug release and skin permeation in vitro studies. In rats, a preclinical trial was conducted to assess the pharmacokinetics (vs. IV/oral), brain targeting (brain-to-plasma ratio), anxiolytic activity (Elevated Plus Maze, Light-Dark Box), and local/systemic safety (histopathology). CZP-NE displayed the best properties droplet size; 152.3 +- 4.1 nm, PDI 0.121, entrapment efficiency; 94.7, and stability. Compared to a control patch, the NE-based patch had 3.8-fold greater steady-state flux (Jss = 4.32 ug/cm2/h) and a reduced lag time. In living subjects, the transdermal patch had an absolute bioavailability of 65.8% (2.7 times greater than oral) and proved to be substantially brain targeting, with a brain-to-plasma ratio (Kp) of 2.97 and Drug Targeting Index of 2.45. The Consistent behavioral tests indicated a significant anxiolytic activity which was similar to a positive control. The patch was not irritating and there was no evidence of local and systemic toxicity. The nanoemulsion transdermal patch containing clonazepam was able to promote skin penetration, deliver systemically with high bioavailability and active targeting of the brain with a high anxiolytic effect and a favorable safety profile. This platform is a promising, patient compliant method of managing anxiety disorders better.

Zitieren

APA

Chamoli, M., Gautam, S., Sharma, M., Wankhede, S. V., Kumar, M., Kondaveeti, S. B., Karodi, R. S., Gupta, M. K., & Kumar, R. (2026). Development of A Nano-Emulsion-Based Transdermal Patch for Enhanced Permeation of Anti-Anxiety Drugs. Oriental Journal Of Chemistry, 1(42), 272. https://doi.org/10.13005/ojc/420130

Vancouver

Chamoli M, Gautam S, Sharma M, Wankhede SV, Kumar M, Kondaveeti SB, et al. Development of A Nano-Emulsion-Based Transdermal Patch for Enhanced Permeation of Anti-Anxiety Drugs. Oriental Journal Of Chemistry. 2026;1(42):272. doi:10.13005/ojc/420130

BibTeX
@article{Chamoli2026,
  author = {Chamoli, Mrynal and Gautam, Swati and Sharma, Manisha and Wankhede, Sujata Vinod and Kumar, Mohit and Kondaveeti, Suresh Babu and Karodi, Revan Sudhakar and Gupta, Mahesh Kumar and Kumar, Ritesh},
  title = {Development of A Nano-Emulsion-Based Transdermal Patch for Enhanced Permeation of Anti-Anxiety Drugs},
  journal = {Oriental Journal Of Chemistry},
  year = {2026},
  volume = {1},
  number = {42},
  pages = {272},
  doi = {10.13005/ojc/420130}
}
Kostenlos starten →